Search company, investor...

Founded Year



Acquired | Acquired

Total Raised


About TrialScope

TrialScope specializes in clinical trial transparency and compliance. The company's tools and systems enable its customers to improve their clinical trial process, mitigate registry and lifecycle risk, and ultimately achieve greater business success. Capabilities include seamless clinical transparency and integration with internal data services such as CTMS platforms. TrialScope technology offers a fully validated SaaS platform hosted in a private cloud. On February 9, 2021, TrialScope was acquired by Informa. The terms of the transaction were not disclosed.

Headquarters Location

Harborside 5 185 Hudson Street, Suite 2900

Jersey City, New Jersey, 07311,

United States




Expert Collections containing TrialScope

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

TrialScope is included in 1 Expert Collection, including Digital Health.


Digital Health

10,804 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.

Latest TrialScope News

Introducing Citeline’s TrialScope Disclose: Core Data

Feb 1, 2024

Clinical Trial Disclosure Solution Harmonizes Data Across Multiple Regions, Registries February 01, 2024 09:00 ET Citeline NEW YORK, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Submitting clinical trial disclosures across different regions can be a fragmented, cumbersome process. Citeline’s new TrialScope Disclose: Core Data is a unified registry submission platform that helps consolidate and streamline clinical trial disclosure processes. TrialScope Disclose: Core Data features the required global data fields in a single form, allowing for one-time disclosure across multiple registries, including, CTIS and jRCT, with more registries being added in the near future. Core Data eliminates duplicate data entry across registries, streamlining the review/approval process for senior staff and ensuring consistency and efficiency, while its built-in validations and compliance checks reduce risks. “Managing clinical trial disclosures across multiple registries is often done in a piecemeal fashion, leaving the process open to errors and inconsistencies that can lead to noncompliance,” says David Laky, General Manager, Clinical & Regulatory, Citeline. “TrialScope Disclose: Core Data allows for approval and submission from a single source of truth, helping to simplify, harmonize and accelerate the clinical trial disclosure process.” TrialScope Disclose has been the leader in helping clinical trial sponsors prepare their studies for public disclosure for over a decade. With the addition of the Core Data platform, TrialScope Disclose continues to provide cutting-edge disclosure technology to enable seamless regulatory compliance. Learn more about Citeline’s TrialScope Disclose . About Citeline Citeline, a Norstella company, powers a full suite of complementary business intelligence offerings to meet the evolving needs of life science professionals to accelerate the connection of treatments to patients and patients to treatments. These patient-focused solutions and services deliver and analyze data used to drive clinical, commercial, and regulatory-related decisions and create real-world opportunities for growth. Citeline’s global teams of analysts, journalists, and consultants keep their fingers on the pulse of the pharmaceutical, biomedical and medtech industries, covering it all with expert insights: key diseases, clinical trials, drug R&D and approvals, market forecasts, and more. For more information on one of the world’s most trusted health science partners, visit  Citeline and follow on LinkedIn and X . Citeline PR contact:

TrialScope Frequently Asked Questions (FAQ)

  • When was TrialScope founded?

    TrialScope was founded in 2012.

  • Where is TrialScope's headquarters?

    TrialScope's headquarters is located at Harborside 5, Jersey City.

  • What is TrialScope's latest funding round?

    TrialScope's latest funding round is Acquired.

  • How much did TrialScope raise?

    TrialScope raised a total of $17.57M.

  • Who are the investors of TrialScope?

    Investors of TrialScope include Informa, NewSpring Capital, Dublin Capital Partners and Edison Partners.



CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.